Bittencourt PL, Farias AQ, Terra C. Renal failure in cirrhosis: Emerging concepts. World J Hepatol 2015; 7(21): 2336-2343 [PMID: 26413223 DOI: 10.4254/wjh.v7.i21.2336]
Corresponding Author of This Article
Paulo Lisboa Bittencourt, MD, Unit of Gastroenterology and Hepatology, Portuguese Hospital, Clementino Fraga 220, Apto 1901, Ondina, Salvador, BA 40170-050, Brazil. plbbr@uol.com.br
Research Domain of This Article
Gastroenterology & Hepatology
Article-Type of This Article
Minireviews
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
World J Hepatol. Sep 28, 2015; 7(21): 2336-2343 Published online Sep 28, 2015. doi: 10.4254/wjh.v7.i21.2336
Table 1 The diagnosis of hepatorenal syndrome according to the original (1996) and revised (2007) International Ascites Club criteria
Criteria for HRS-1 (1996)
Revised criteria for HRS-1 (2007)
Major criteria
Presence of cirrhosis with ascites
Chronic or acute liver disease with advanced hepatic failure and portal hypertension
SCr > 1.5 mg/dL
Low GFR: SCr > 1.5 mg/mL or 24 h SCr clearance < 40 mL/min
No improvement of SCr levels after at least 2 d of diuretic
Absence of shock, ongoing bacterial infection or treatment with nephrotoxic drugs
withdrawal and volume expansion with albumin (1 g/kg of
or gastrointestinal or renal fluid losses
body weight per day up to a maximum of 100 g/d)
No sustained improvement in renal function following diuretic withdrawal and
Absence of shock
expansion of plasma volume with at least 1500 mL of isotonic saline
No current or recent treatment with nephrotoxic drugs
Proteinuria < 0.5 g/d and no evidence of obstructive nephropathy or
Absence of parenchymal kidney disease as indicated by
parenchymal renal disease on ultrasound
proteinuria > 500 mg/d, microhaematuria (> 50 red blood cells
Additional criteria
per high power field) and/or abnormal renal ultrasonography
Urinary volume < 0.5 L/d
Urinary sodium < 10 mmol/L
Urinary osmolality > plasma osmolality
Urinary red blood cells < 50 high power field
Serum sodium concentration < 130 mmol/L
Table 2 Risk, injury, failure, loss of kidney function and end-stage kidney disease classification for acute kidney injury
Class
Baseline SCr levels and GFR within 7 d
Urinary output
Risk
↑ SCr 1.5-1.9 times over baseline or ↓ GFR > 25%
< 0.5 mL/kg per hour for 6 h
Injury
↑ SCr 2.0-2.9 times over baseline or ↓ GFR > 50%
< 0.5 mL/kg per hour for 12 h
Failure
↑ SCr ≥ 3 times over baseline or ↓ GFR > 75% or if baseline SCr ≥ 4 mg/dL: ↑ SCr > 0.5 mg/dL
< 0.3 mL/kg per hour for 24 h or anuria for 12 h
Loss of kidney function
Complete loss of kidney function > 4 wk
End-stage kidney disease
Complete loss of kidney function > 3 mo
Table 3 The Acute Kidney Injury Network classification of acute kidney injury
Stage
Baseline SCr within 48 h
Urinary output
1
↑ SCr ≥ 0.3 mg/dL or ↑ SCr 1.5-1.9 times over baseline
< 0.5 mL/kg per hour for 6 h
2
↑ SCr 2.0-2.9 times over baseline
< 0.5 mL/kg per hour for 12 h
3
↑ SCr ≥ 3 times over baseline or if baseline SCr ≥ 4 mg/dL: ↑ SCr ≥ 0.5 mg/dL
< 0.3 mL/kg per hour for 24 h or anuria for 12 h
Table 4 International Club of Ascites-acute kidney injury criteria for diagnosis, grading, assessment of progression and response to treatment of acute kidney injury in patients with cirrhosis
Class
Baseline SCr within 3 mo, most recent prior to hospital admission
Urinary output
I
↑ SCr ≥ 0.3 mg/dL or ↑ SCr 1.5-1.9 times over baseline1
↑ SCr ≥ 3 times over baseline or if baseline SCr ≥ 4 mg/dL: ↑ SCr ≥ 0.3 mg/dL1 or initiation of renal replacement therapy
Not required
Progression of AKI
Progression of AKI to a higher stage and/or need for renal replacement therapy
Regression of AKI
Regression of AKI to a lower stage
No response
No regression of AKI
Partial response
Regression of AKI stage with a reduction of SCr to ≥ 0.3 mg/dL above the baseline value
Full response
Return of SCr to a value within 0.3 mg/dL of the baseline value
Table 5 Updated diagnosis of hepatorenal syndrome type of acute kidney injury according to the International Club of Ascites
Presence of cirrhosis with ascites
Diagnosis of AKI according to ICA-AKI criteria
No improvement of SCr after at least 2 d of diuretic withdrawal and volume expansion with albumin (1 g/kg of body weight per day up to a maximum of 100 g/d)
Absence of shock
No current or recent treatment with nephrotoxic drugs
No macroscopic signs of structural kidney injury: normal findings on renal ultrasonography, absence of proteinuria > 500 mg/d and absence of microhematuria
Citation: Bittencourt PL, Farias AQ, Terra C. Renal failure in cirrhosis: Emerging concepts. World J Hepatol 2015; 7(21): 2336-2343